Biocon Limited
Biocon Limited (India) holds 69 active US FDA Type II Drug Master Files and 14 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 5 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Biocon Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/biocon-limited
Overview
Biocon Limited is an Indian biopharmaceutical company that focuses on developing affordable biosimilars and generic formulations. The company is committed to advancing healthcare by providing high-quality, innovative therapies for chronic diseases. Biocon operates across several segments, including biologics, branded formulations, and research services.
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Biocon Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Biocon Limited holds 69 active (83 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- TEDUGLUTIDEActive2026-03-31
- RELUGOLIXActive2026-03-30
- TRAMETINIB DIMETHYL SULFOXIDEActive2026-03-24
- EDOXABAN TOSYLATE MONOHYDRATEActive2026-01-28
- ELTROMBOPAG OLAMINEActive2025-11-30
- TIRZEPATIDEActive2025-11-24
- POSACONAZOLE (FORM-1)Active2025-10-17
- ENZALUTAMIDEActive2025-09-20
- NINTEDANIB ESYLATEActive2025-03-29
- OLAPARIBActive2025-03-26
- LINAGLIPTIN PROCESS IIActive2025-03-19
- IVACAFTORActive2025-02-28
- TICAGRELOR PH. EURActive2024-12-27
- SEMAGLUTIDEActive2024-12-21
- ROSUVASTATIN CALCIUM USP (PROCESS-III)Active2024-07-14
- SITAGLIPTIN HYDROCHLORIDE (ENZYMATIC)Active2024-03-22
- TACROLIMUS USP (PROCESS II)Active2024-03-21
- LURASIDONE HYDROCHLORIDEActive2024-03-21
- VILDAGLIPTINActive2023-11-10
- CABOZANTINIB-(S)-MALATEActive2023-09-28
- SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2023-08-31
- ORLISTAT USPActive2023-04-12
- FLUVASTATIN SODIUMActive2022-02-28
- SITAGLIPTIN HYDROCHLORIDEActive2022-02-06
- POSACONAZOLEActive2022-02-01
- EMPAGLIFLOZINActive2021-11-30
- DASATINIB MONOHYDRATEActive2021-09-30
- LIRAGLUTIDEActive2021-09-01
- DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATEActive2021-07-05
- LINAGLIPTINActive2021-06-01
- EVEROLIMUS PREMIX 2%Active2021-04-01
- RIVAROXABAN USPActive2020-12-31
- APIXABANActive2020-12-31
- MIRABEGRONActive2020-09-30
- SITAGLIPTIN PHOSPHATE MONOHYDRATEActive2020-07-31
- LENALIDOMIDEActive2020-07-31
- SACUBITRIL SODIUMActive2019-04-26
- VALSARTAN DISODIUMActive2019-03-15
- DABIGATRAN ETEXILATE MESYLATEActive2018-09-28
- SITAGLIPTIN PHOSPHATEActive2018-09-28
- ANIDULAFUNGIN (DRUG SUBSTANCE INTERMEDIATE)Active2018-06-12
- EVEROLIMUS (2% BHT)Active2018-05-02
- POSACONAZOLEActive2018-03-29
- DAPAGLIFLOZINActive2017-07-03
- MICAFUNGIN SODIUMActive2016-09-30
- TERIFLUNOMIDEActive2016-03-05
- EVEROLIMUS (WITH 0.2% BHT)Active2015-09-30
- EVEROLIMUSActive2015-09-30
- PIMECROLIMUS USPActive2015-09-30
- DRUG SUBSTANCE INTERMEDIATE IMMUNOMYCINActive2015-09-28
Showing the 50 most relevant of 83 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (5)
Physical sites registered with the US FDA and resolved to Biocon Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Biocon Limited in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Biocon Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.